Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg; T Kringelbach; N Bolstad; D J Warren; G Eng; I J Sørensen; A G Loft; O Hendricks; Imj Hansen; A Linauskas; H Nordin; S Kristensen; H Lindegaard; D V Jensen; G L Goll; E Høgdall; J Gehin; C Enevold; C H Nielsen; N S Krogh; J S Johansen; M L Hetland

doi:10.1080/03009742.2017.1376110

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg, T Kringelbach, N Bolstad, D J Warren, G Eng, I J Sørensen, A G Loft, O Hendricks, Imj Hansen, A Linauskas, H Nordin, S Kristensen, H Lindegaard, D V Jensen, G L Goll, E Høgdall, J Gehin, C Enevold, C H Nielsen, N S KroghJ S Johansen, M L Hetland

Department of Clinical Medicine

8 Citations (Scopus)

Original language	English
Journal	Scandinavian Journal of Rheumatology
Volume	47
Issue number	5
Pages (from-to)	418-421
ISSN	0300-9742
DOIs	https://doi.org/10.1080/03009742.2017.1376110
Publication status	Published - 3 Sept 2018

Keywords

Adult
Aged
Antibodies/blood
Antibodies, Monoclonal/blood
Arthritis/blood
Denmark
Female
Follow-Up Studies
Humans
Infliximab/administration & dosage
Male
Middle Aged

Access to Document

10.1080/03009742.2017.1376110

Cite this

Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., ... Hetland, M. L. (2018). Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. Scandinavian Journal of Rheumatology, 47(5), 418-421. https://doi.org/10.1080/03009742.2017.1376110

Glintborg, B, Kringelbach, T, Bolstad, N, Warren, DJ, Eng, G, Sørensen, IJ, Loft, AG, Hendricks, O, Hansen, I, Linauskas, A, Nordin, H, Kristensen, S, Lindegaard, H, Jensen, DV, Goll, GL, Høgdall, E, Gehin, J, Enevold, C, Nielsen, CH, Krogh, NS, Johansen, JS & Hetland, ML 2018, 'Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care', Scandinavian Journal of Rheumatology, vol. 47, no. 5, pp. 418-421. https://doi.org/10.1080/03009742.2017.1376110

@article{a05b34946fb64779af822bfed56a47ff,

title = "Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care",

keywords = "Adult, Aged, Antibodies/blood, Antibodies, Monoclonal/blood, Arthritis/blood, Denmark, Female, Follow-Up Studies, Humans, Infliximab/administration & dosage, Male, Middle Aged",

author = "B Glintborg and T Kringelbach and N Bolstad and Warren, {D J} and G Eng and S{\o}rensen, {I J} and Loft, {A G} and O Hendricks and Imj Hansen and A Linauskas and H Nordin and S Kristensen and H Lindegaard and Jensen, {D V} and Goll, {G L} and E H{\o}gdall and J Gehin and C Enevold and Nielsen, {C H} and Krogh, {N S} and Johansen, {J S} and Hetland, {M L}",

year = "2018",

month = sep,

day = "3",

doi = "10.1080/03009742.2017.1376110",

language = "English",

volume = "47",

pages = "418--421",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "5",

}

TY - JOUR

T1 - Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

AU - Glintborg, B

AU - Kringelbach, T

AU - Bolstad, N

AU - Warren, D J

AU - Eng, G

AU - Sørensen, I J

AU - Loft, A G

AU - Hendricks, O

AU - Hansen, Imj

AU - Linauskas, A

AU - Nordin, H

AU - Kristensen, S

AU - Lindegaard, H

AU - Jensen, D V

AU - Goll, G L

AU - Høgdall, E

AU - Gehin, J

AU - Enevold, C

AU - Nielsen, C H

AU - Krogh, N S

AU - Johansen, J S

AU - Hetland, M L

PY - 2018/9/3

Y1 - 2018/9/3

KW - Adult

KW - Aged

KW - Antibodies/blood

KW - Antibodies, Monoclonal/blood

KW - Arthritis/blood

KW - Denmark

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Infliximab/administration & dosage

KW - Male

KW - Middle Aged

U2 - 10.1080/03009742.2017.1376110

DO - 10.1080/03009742.2017.1376110

M3 - Letter

C2 - 29310493

SN - 0300-9742

VL - 47

SP - 418

EP - 421

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 5

ER -